Compare REXR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REXR | RVTY |
|---|---|---|
| Founded | 2013 | 1937 |
| Country | United States | United States |
| Employees | 256 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 9.7B |
| IPO Year | N/A | 1994 |
| Metric | REXR | RVTY |
|---|---|---|
| Price | $34.86 | $94.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 16 |
| Target Price | $41.00 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 2.0M | 1.4M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.90% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $0.09 | $6.37 |
| Revenue Next Year | $2.99 | $5.10 |
| P/E Ratio | ★ $43.28 | $268.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.14 | $81.22 |
| 52 Week High | $44.38 | $118.30 |
| Indicator | REXR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 52.93 |
| Support Level | $32.14 | $94.57 |
| Resistance Level | $41.92 | $95.63 |
| Average True Range (ATR) | 0.65 | 4.11 |
| MACD | -0.13 | 0.52 |
| Stochastic Oscillator | 14.04 | 61.54 |
Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.